generic glp-1 medications drugs may help Medicare negotiate semaglutide price GLP-1 Agonist Therapy Center -
Description
The study analyzed national electronic health record data from older U.S
Gault et al
doi: 10.1016/j.ejphar.2012.12.012 143 McCleanPLJalewaJHolscherC
Centers for Disease Control and Prevention (CDC) data show that over 100 million US adults are obese, PwC noted, while an analysis published in JAMA Cardiology in November determined that 137 million Americans may be eligible for the GLP-1 drug semaglutide (prescribed as Wegovy for weight loss and Ozempic for type 2 diabetes)
